GNPX
Price
$0.36
Change
-$0.12 (-25.00%)
Updated
Oct 17 closing price
Capitalization
15.57M
TYRA
Price
$14.50
Change
-$0.34 (-2.29%)
Updated
Oct 17 closing price
Capitalization
772.81M
12 days until earnings call
Interact to see
Advertisement

GNPX vs TYRA

Header iconGNPX vs TYRA Comparison
Open Charts GNPX vs TYRABanner chart's image
Genprex
Price$0.36
Change-$0.12 (-25.00%)
Volume$51.68M
Capitalization15.57M
Tyra Biosciences
Price$14.50
Change-$0.34 (-2.29%)
Volume$161.39K
Capitalization772.81M
GNPX vs TYRA Comparison Chart in %
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNPX vs. TYRA commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Hold and TYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (GNPX: $0.36 vs. TYRA: $14.50)
Brand notoriety: GNPX and TYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 147% vs. TYRA: 79%
Market capitalization -- GNPX: $15.57M vs. TYRA: $772.81M
GNPX [@Biotechnology] is valued at $15.57M. TYRA’s [@Biotechnology] market capitalization is $772.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 1 FA rating(s) are green whileTYRA’s FA Score has 1 green FA rating(s).

  • GNPX’s FA Score: 1 green, 4 red.
  • TYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, GNPX is a better buy in the long-term than TYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 5 TA indicator(s) are bullish while TYRA’s TA Score has 5 bullish TA indicator(s).

  • GNPX’s TA Score: 5 bullish, 4 bearish.
  • TYRA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GNPX is a better buy in the short-term than TYRA.

Price Growth

GNPX (@Biotechnology) experienced а +76.89% price change this week, while TYRA (@Biotechnology) price change was +7.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

TYRA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TYRA($773M) has a higher market cap than GNPX($15.6M). TYRA YTD gains are higher at: 4.317 vs. GNPX (-57.386). GNPX has higher annual earnings (EBITDA): -17.31M vs. TYRA (-121.07M). TYRA has more cash in the bank: 296M vs. GNPX (1.35M). GNPX has less debt than TYRA: GNPX (279K) vs TYRA (6.02M). GNPX (0) and TYRA (0) have equivalent revenues.
GNPXTYRAGNPX / TYRA
Capitalization15.6M773M2%
EBITDA-17.31M-121.07M14%
Gain YTD-57.3864.317-1,329%
P/E Ratio0.43N/A-
Revenue00-
Total Cash1.35M296M0%
Total Debt279K6.02M5%
FUNDAMENTALS RATINGS
GNPX: Fundamental Ratings
GNPX
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNPXTYRA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCBO26.280.51
+2.00%
Docebo
BFRG1.47N/A
N/A
Bullfrog AI Holdings
CARG34.92-0.33
-0.94%
CarGurus
SXTC1.39-0.03
-2.11%
China SXT Pharmaceuticals Inc.
NBIS113.44-9.60
-7.80%
Nebius Group N.V.

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
-23.68%
REVB - GNPX
48%
Loosely correlated
-3.01%
HOWL - GNPX
38%
Loosely correlated
-4.19%
OMER - GNPX
34%
Loosely correlated
-17.55%
AXON - GNPX
30%
Poorly correlated
+2.84%
TYRA - GNPX
30%
Poorly correlated
-2.29%
More

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with NUVL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
-2.29%
NUVL - TYRA
49%
Loosely correlated
+2.32%
NRIX - TYRA
47%
Loosely correlated
-1.89%
AURA - TYRA
46%
Loosely correlated
-8.40%
KYMR - TYRA
43%
Loosely correlated
-1.04%
XNCR - TYRA
42%
Loosely correlated
-1.20%
More